These inactivating TET2 mutations suggest a tumor suppressive role for the TET2 protein, which is confirmed by the spontaneous development of myeloid, T-cell, and B-cell malignancies in a TET2 KO mouse model (149). The gene discussed is TET2; the disease is neoplasm.